Home
Per Magne Ueland's picture

Per Magne Ueland

Professor
  • E-mailPer.Ueland@uib.no
  • Phone+47 55 97 31 47+47 405 55 082
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • 2010. Uracil misincorporation into DNA and folic acid supplementation. American Journal of Clinical Nutrition. 160-165.
  • 2010. Maternal homocysteine and related B vitamins as risk factors for low birthweight. American Journal of Obstetrics and Gynecology. 572.e1-572.e6.
  • 2010. Infant birth size is not associated with maternal intake and status of folate during the second trimester in norwegian pregnant women. Journal of Nutrition. 572-579.
  • 2010. Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. Journal of Internal Medicine. 367-382.
  • 2010. Analytical Recovery of Folate and Its Degradation Products in Human Serum Stored at-25 degrees C for up to 29 Years. Journal of Nutrition. 522-526.
  • 2009. Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 1371-1379.
  • 2009. Nested case-control study of one-carbon metabolites in mid-pregnancy and risks of cleft lip with and without cleft palate. Pediatric Research. 501-506.
  • 2009. Choline and risk of neural tube defects in a folate-fortified population. Epidemiology. 714-719.
  • 2008. Measurement of folate in fresh and archival serum samples as p-aminobenzoylglutamate equivalents. Clinical Chemistry. 665-672.
  • 2008. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism? American Journal of Clinical Nutrition. 738-746.
  • 2008. Folic acid and multivitamin supplement use and risk of placental abruption: A population-based registry study. American Journal of Epidemiology. 867-874.
  • 2008. Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. Journal of Nutrition. 914-920.
  • 2007. Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 514-521.
  • 2007. Plasma vitamin B-6 forms and their relation to transsulfuration metabolites in a large, population-based study. American Journal of Clinical Nutrition. 131-138.
  • 2007. Plasma creatinine as a determinant of plasma total homocysteine concentrations in the Hordaland Homocysteine Study: Use of statistical modeling to determine reference limits. Clinical Biochemistry. 1209-1218.
  • 2007. Modulation of the homocysteine-betaine relationship by methylenetetrahydrofolate reductase 677 C-> T genotypes and B-vitamin status in a large-scale epidemiological study. Journal of Clinical Endocrinology and Metabolism. 1535-1541.
  • 2007. Low vitamin B-12 status and risk of cognitive decline in older adults. American Journal of Clinical Nutrition. 1384-1391.
  • 2007. Longitudinal study of the effect of pregnancy on maternal and fetal cobalamin status in healthy women and their offspring. Journal of Nutrition. 1863-1867.
  • 2007. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. Journal of Internal Medicine. 244-253.
  • 2007. Folic acid for the prevention of colorectal adenomas - A randomized clinical trial. Journal of the American Medical Association (JAMA). 2351-2359.
  • 2007. Dietary predictors of plasma total homocysteine in the Hordaland Homocysteine Study. British Journal of Nutrition. 201-210.
  • 2007. Dietary fat and plasma total homocysteine concentrations in 2 adult age groups: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 1598-1605.
  • 2007. Detection of vitamin B-12 deficiency in older people by measuring vitamin B-12 or the active fraction of vitamin B-12, holotranscobalamin. Clinical Chemistry. 963-970.
  • 2006. The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease. Journal of Nutrition. 1731-1740.
  • 2006. Mid-trimester amniotic fluid methionine concentrations: a predictor of birth weight and length. Metabolism: Clinical and Experimental. 1186-1191.
  • 2006. Low fasting methionine concentration as a novel risk factor for recurrent venous thrombosis. Thrombosis and Haemostasis. 492-497.
  • 2006. Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. American Heart Journal. 282-287.
  • 2006. Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. American Heart Journal. 282-287.
  • 2006. Homocysteine lowering and cardiovascular events after acute myocardial infarction. New England Journal of Medicine. 1578-1588.
  • 2006. Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. QJM: Quarterly journal of medicine. 289-298.
  • 2006. Factor V Leiden, pregnancy complications and adverse outcomes: The Hordaland Homocysteine Study. QJM: Quarterly journal of medicine.
  • 2006. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. American Journal of Clinical Nutrition. 361-370.
  • 2006. Clinical relevance of low serum vitamin B12 concentrations in older people: the Banbury B12 study. Age and Ageing. 416-422.
  • 2005. Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study. Annals of Neurology. 847-857.
  • 2004. Vitamin B12 and folate deficiency in later life. Age and Ageing. 34-41.
  • 2004. Screening for serum total homocysteine in newborn children. Clinical Chemistry. 1769-1784.
  • 2004. Screening for serum total homocysteine in newborn children. Clinical Chemistry. 1769-1784.
  • 2004. Phenotypic expression of the methylenetetrahydrofolate reductase 677C->T polymorphism and flavine cofactor availability in thyroid dysfunction. American Journal of Clinical Nutrition. 1050-1057.
  • 2004. High-level multiplex genotyping of polymorphisms involved in folate or homocysteine metabolism by matrix-assisted laser desorption/ionization mass spectrometry. Clinical Chemistry. 391-402.
  • 2004. Hematological parameters and cobalamin status in infants born to smoking mothers. Biology of the Neonate. 249-255.
  • 2004. Colorectal cancer and the methylenetetrahydrofolate 677C->T and methionine synthase 2756A->G polymorphism. A study of 2168 case-control pairs from the Janus cohort. Cancer Epidemiology, Biomarkers and Prevention. 2175-2180.
  • 2004. Colorectal Cancer and the Methylenetetrahydrofolate Reductase 677C - T and Methionine Synthase 2756A - G Polymorphisms: A Study of 2, 168 Case-Control Pairs from the JANUS Cohort. Cancer Epidemiology, Biomarkers and Prevention. 2175-2180.
  • 2004. Changes in lifestyle and plasma total homocysteine. The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 812-819.
  • 2004. Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention. American Journal of Clinical Nutrition. 641-648.
  • 2004. Birth prevalence of homocystinuria. Journal of Pediatrics. 830-832.
  • 2004. Birth prevalence of homocystinuria. Journal of Pediatrics. 830-832.
  • 2004. Biochemical signs of impaired cobalamin status during and after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics. 807-813.
  • 2004. Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation. Arteriosclerosis, Thrombosis and Vascular Biology. 301-307.
  • 2004. Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: The Hordaland Homocysteine Study. American Journal of Medicine. 26-31.
  • 2004. Associations between maternal methylenetetrahydrofolate reductase polymorhpisms and adverse outcomes of pregnancy: The Hordaland Homocysteine Study. American Journal of Medicine. 26-31.
  • 2000. The controversy over homocysteine and cardiovascular risk. American Journal of Clinical Nutrition. 324-332.
  • 2000. Signs of impaired cognitive function in adolescents with marginal cobalamin status. American Journal of Clinical Nutrition. 762-769.
  • 2000. Riboflavin as a determinant og plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clinical Chemistry. 1065-1071.
  • 2000. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. American Journal of Clinical Nutrition. 962-968.
  • 2000. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 962-968.
  • 1999. Influence of aromatase inhibitors on plasma total homocysteine levels in postmenopausal breast cancer patients. Clinical Chemistry. 252-256.
  • 1999. Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clinical Chemistry. 189-198.
  • 1998. Variability and determinants of total homocysteine concentrations in plasma in an elderly population. Clinical Chemistry. 102-107.
  • 1998. The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine. Journal of Pediatrics. 365-368.
  • 1998. Simultaneous determination of methylenetetrahydrofolate reductase C677T and factor V G1691A genotypes by mutagenically separated PCR and multiple-injection capillary electrophoresis. Clinical Chemistry. 264-269.
  • 1998. Quantitation of total homocysteine, total cysteine and cystathionine in human plasma and serum by gas chromatography-mass spectometry (GC-MS). Netherlands Journal of Medicine. S39.
  • 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • 1998. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study [see comments]. American Journal of Clinical Nutrition. 263-270.
  • 1998. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 263-270.
  • 1998. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European C Group [see comments]. Circulation. 437-443.
  • 1998. Kinetics of total plasma homocysteine during basal conditions. Clinical Chemistry. 1886-1891.
  • 1998. Kinetics of plasma total homocysteine in patients receiving high-dose methotrexate therapy. Clinical Chemistry. 1987-1989.
  • 1998. Kinetics of plasma total homocysteine in patients receiving high- dose methotrexate therapy. Clinical Chemistry. 1987-1989.
  • 1998. Hyperhomocysteinemia in terms of steady-state kinetics. European Journal of Pediatrics. S45-S49.
  • 1998. Hyperhomocysteinemia in terms of steady-state kinetics. European Journal of Pediatrics. S45-9.
  • 1998. Homocysteine and cardiovascular disease. Annual Review of Medicine. 31-62.
  • 1998. Homocysteine and cardiovascular disease. Annual Review of Medicine. 31-62.
  • 1998. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Archives of Neurology. 1449-1455.
  • 1998. Disruption of a regulatory system involving cobalamin distribution and function in a methionine-dependent human glioma cell line. Journal of Biological Chemistry. 20180-20184.
  • 1998. Disruption of a Regulatory system Involving Cobalamin distribution and Function in a Methionine-dependent Human glioma Cell Line. Journal of Biological Chemistry. 20180-20184.
  • 1998. Chemical mismatch cleavage combined with capillary electrophoresis: detection of mutations exon 8 of the cystathionine beta-synthase gene. Clinical Chemistry. 2108-2114.
  • 1998. Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients. Clinical Cancer Research. 2125-2128.
  • 1998. Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients. Clinical Cancer Research. 2125-2128.
  • 1997. The 677C-T mutation in the methylenetetrahydrofolate reductase gene: assosiations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis. 105-113.
  • 1997. Plasma total homocysteine, B-vitamins and risk of coronary atherosclerosis. Arteriosclerosis, Thrombosis and Vascular Biology. 989-995.
  • 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • 1997. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project. Journal of the American Medical Association (JAMA). 1775-1781.
  • 1997. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney International. 495-502.
  • 1997. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney International. 495-502.
  • 1997. Homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. Norsk Epidemiologi. 221-224.
  • 1997. Homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. Norsk Epidemiologi. 221-224.
  • 1997. Functional modeling of vitamin responsivness in yeast: a commom pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria. Hum Mol Genetics. 2213-2221.
  • 1997. Functioinal modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cysatihione b-synthase mutation i homocyteinuria. Human Molecular Genetics. 2213-2221.
  • 1997. Folate depletion induced by methotrexate affects methionine synthase activity and its susceptibility to inactivation by nitrous oxide. Journal of Pharmacology and Experimental Therapeutics. 1305-1311.
  • 1997. Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida. Quarterly Journal of Medicine. 593-596.
  • 1997. Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida. Quarterly Journal of Medicine. 593-596.
  • 1997. Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida. Quarterly Journal of Medicine. 593-596.
  • 1997. Elevated plasma levels of reduced homocysteine in common variable immunodeficiency - a marker of enhanced oxidative stress. European Journal of Clinical Investigation. 723-730.
  • 1997. Elevated plasma levels of reduced homocysteine in common variable immunodeficiency - a marker of enhanced oxidative stress. European Journal of Clinical Investigation. 723-730.
  • 1997. Elevated plasma levels of reduced homocysteine in common variable immunodeficiency - a marker of enhanced oxidative stress. European Journal of Clinical Investigation. 730-790.
  • 1997. Effects of hormones on the plasma levels of the atherogenic amino acid homocysteine. Biochemical Society Transactions. 33-35.
  • 1997. Effects of hormones on the plasma level of the atherogenic amino acid homocysteine. Biochemical Society Transactions. 33-35.
  • 1997. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • 1997. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • 1997. C677T mutation of methylenetetrahydrofolate reductase gene determined in blood or plasma by multiple injection capillary electrophoresis and laser-induced fluorescence detection. Clinical Chemistry. 267-272.
  • 1997. Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia. Circulation. 1803-1808.
  • 1997. Assessment of homocysteine status. Journal of Inherited Metabolic Disease. 286-294.
  • 1997. Analysis of single-strand conformation polymorphism by capillary electrophoresis with laser-induced flourescence detection using short-chain polyacrylamide as sieving medium. Analytical Biochemistry. 79-84.
  • 1996. The Hordaland homocysteine study: The opposite tails odds ratios (OTOR) reveal differential effects og gender and intake of vitamin supplements at high and low plasma homocysteine concentrations. Journal of Nutrition. 1244S-1248S.
  • 1996. Relation of homocysteine and lipid levels in children to premature cardiovascular death in male relatives. Pediatric Research. 47-52.
  • 1996. Kinetics of plasma Homocysteine in subject with hyperhomocysteiemia due to folate or cobalamin deficiency. American Journal of Clinical Nutrition. 194-202.
  • 1996. Determinants and vitamin responsiveness of the intermediate homohypercysteinemia (> 40 _mmol/L). The Hordaland homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • 1996. Determinants and Vitamin Responsiveness of Intermediate Hyperhomocysteinemia (@z _mmol/liter). The Hordaland Homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • 1995. Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen. International Journal of Cancer. 365-368.
  • 1995. Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen. International Journal of Cancer. 365-368.
  • 1995. Pharmacokinetics of tamoxifen in pre- and post-menopausal women with breast cancer. Journal of Steroid Biochemistry and Molecular Biology. 229-231.
  • 1995. Determination of droloxifene and two metabolites in serum by high-pressure liquid chromatography. Therapeutic Drug Monitoring. 259-265.
  • 1995. Determination of droloxifene and two metabolites in serum by high pressure liquid chromatography. Therapeutic Drug Monitoring. 259-265.
  • 1995. Application of capillary electrophoresis with laser-induced fluorescence detection for routine analysis of methylmalonic acid in human serum. Analytical Chemistry. 812-819.
  • 1994. The spectral viscosity method applied to simulation of waves in stratified atmosphere. Journal of Computational Physics. 257-273.
  • 1994. Preoperative Methionine loading enhances restoration of the cobalamin-dependent enzyme methionine synthase after nitrous oxide anesthesia. Anesthesiology. 1046-1056.
  • 1993. Redox status and Protein-binding of aminothiols during the transient hyperhomocysteinemia that follows homocysteine administration. Clinical Chemistry. 980-985.
  • 1993. Kinetics of plasma homocysteine in healthy subjects after peroral homocysteine loading. Clinical Chemistry. 1390-1397.
  • 1993. Automated assay for methylmalonic acid in serum and urine based on derivation with 1-pyrenyldiazomethane, liquid chromatography and fluorescence detection. Clinical Chemistry. 392-399.
  • 1992. The formation in an aqueous matrix, properties, and chromatographic behaviour of 1-pyrenyldiazomethane derivatives of methylmalonic acid and other short chain dicarboxylic acids. Analytical Chemistry. 315-319.
  • 1992. Dynamic relation between reduced, oxidized and protein-bound homocysteine and other thiols components in plasma during methionine loading in healthy men. Clinical Chemistry. 1316-1321.
  • 1991. Monitoring cobalamin inactivation during nitrous oxide anesthesia by determination of homocysteine and folate in plasma and urine. Clinical Pharmacology and Therapeutics. 385-393.
  • 1991. Monitoring cobalamin inactivation during nitrous oxide anesthesia by determination of homocysteine and folate in plasma and urine. Clinical Pharmacology and Therapeutics. 385-393.
  • 1991. Bestemmelse av homocystein og metylmalonsyre ved kobalaminmangel. Tidsskrift for Den norske legeforening. 450-455.
  • 1990. Decreased serum concentrations of tamoxifen and its metabolites induced by aminogluethimide. Cancer Research. 5851-5857.
Academic lecture
  • 2019. Circulating 3-hydroxyisobutyrate (3-HIB) as a clinical marker of prediabetes and T2D in patients with obesity.
  • 2018. Using metabolic profiling to explore molecular effects of replacing saturated fat with polyunsaturated fat- a randomized controlled dietary intervention study.
  • 2018. Amino acid metabolism in adipocytes.
  • 2017. Pregnancy fatty acid status and newborn DNA methylation: the MoBa pregnancy cohort.
  • 2015. Plasma Interferon-inducible Protein 10 Levels, T-cell Activation and Regulation are Increased in HIV Immunological Non-Responders.
  • 2015. Fibrinogen And Neopterin Predict Future Myocardial Infarction Events In Patients With Stable Coronary Heart Disease. Circulation. 2015;132:A19224.
  • 2010. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.
  • 2007. WENBIT -Western Norway B-vitamin Intervention Trial: P96, Clinical Chemistry & Laboratory Medicine. 45(5):A18, May 2007.
  • 2007. Total homocysteine, systemic markers of inflammation and long-term mortality in patients with stable angina.
  • 2007. High-level multiplex genotyping of single nucleotide polymorphisms involved in one-carbon metabolism by Matrix-assisted Laser Desorption/Ionization Mass Spectrometry.
  • 2007. High-level multiplex genotyping of polymorphisms involved in one-carbon metabolism by MALDI-TOF MS.
  • 2007. Components of the metabolic syndrome and other cardiovascular risk factors as predictors of plasma choline and betaine.
  • 2007. Asymmetric and symmetric dimethylarginine are weaker predictors than homocysteine of long-term mortality in patients with stable angina.
  • 2007. A novel serum folate assay measuring intact and degraded folate species as para-aminobenzoylglutamate equivalents in fresh and stored samples.
  • 2007. A high-throughput method for quantification of riboflavin, vitamin B6 forms, related metabolites and inflammation markers in human plasma by HPLC-MS/MS.
  • 2006. High throughput genotyping of single nucleotide polymorphisms by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
  • 2005. High Troughput Genotyping of SNP by MALDI-TOF MS.
  • 2005. Folate, but not cobalamin status predicts respiratory morbidity in north Indian children.
  • 2005. Effects of polymorphisms in genes related to the folate and homocysteine metabolism in a Norwegian population.
  • 2005. Effect of daily zinc supplementation for 4 months on plasma concentrations of folate, cobalamin, and other markers of B-vitamin status: A randomized placebo-controlled trial in young north Indian children.
  • 2004. Prevalence determination of 13 polymorphisms in a Norwegian population by MALDI-TOF MS.
  • 2003. HPLC-MS-MS assay for the determination of all forms of vitamins B2 and B6 in human plasma.
  • 2002. Total homocysteine levels predicts major coronary events and mortaliy in simvastatin treated patients of 4S.
  • 2001. Total Homocysteine Levels Predicts Major Coronary Events and Mortality in Simvastatin Treated Patients of 4S.
  • 2001. Predictors of 6-years changes in plasma total homocysteine: The Hordaland Homocysteine Study.
  • 2001. Plasma total homocysteine and hospitalizations for cardiovascular disease: The Hordaland Homocysteine Study.
  • 2001. Plasma total homocysteine and hospitalizations for cardiovascular disease: The Hordaland Homocysteine Study.
  • 1999. Plasma levels of homocysteine are changed during treatment of hyper- and hypothyroidism.
  • 1998. Mastcelletryptase og kvantitering av IgE antistoffer mot ammonium grupper, thilopental og cholin (suxameton) hos 25 pasienter med anafylaktisk sjokk under induksjon av generell anestesi.
  • 1997. Total plasma homocysteine and previous occurrence of congenital malformations: The Hordaland Homocysteine Study.
  • 1997. Total plasma homocysteine and previous occurrence of congenital malformations: The Hordaland Homocysteine Study.
  • 1997. Total plasma homocysteine and previous occurrence of congenital malformations: The Hordaland Homocysteine Study.
  • 1997. Total mortality and serum uric acid in patients with confirmed coronary artery disease.
  • 1997. Plasma homocysteine predicts mortality in coronary artery diseased patients.
  • 1997. Plasma homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. [Poster].
  • 1995. Plasma homocysteine and relation to coffee and tea comsimption.
  • 1995. Plasma homocystein og forbruk av kaffe og te.
Abstract
  • 2013. DETERMINANTS OF VITAMIN D STATUS IN PATIENTS WITH STABLE ANGINA. Annals of Nutrition and Metabolism. 241-241.
  • 2012. Relationship between plasma choline and betaine levels and risk of acute myocardial infarction in patients with stable coronary heart disease. European Heart Journal. 132-132.
  • 2012. Plasma dimethylglycine is an independent risk factor of acute myocardial infarction in patients with stable angina pectoris. European Heart Journal. 510-510.
  • 2011. Hematological parameters and iron status in infants with a birthweight below 3000 g. Clinical Biochemistry. 524-524.
  • 2011. Cobalamin supplementation improves motor development and gastrointestinal reflux in moderately deficient infants. Clinical Biochemistry. 524-525.
  • 2010. Maternal Folate Levels in Pregnancy and Asthma at 3 Years of Age. Journal of Allergy and Clinical Immunology. AB128-AB128.
  • 2009. VITAMIN B12, BUT NOT FOLATE STATUS PREDICTS MENTAL DEVELOPMENT SCORES IN NORTH INDIAN TODDLERS. Annals of Nutrition and Metabolism. 691-692.
  • 2009. DOES VITAMIN B12 OR FOLATE STATUS MODIFY THE IMPACT OF ZINC SUPPLEMENTATION ON THE INCIDENCE OF DIARRHEA? Annals of Nutrition and Metabolism. 261-262.
  • 2008. The ratio of apolipoproteins ApoB/ApoA1 as a predictor of angiographic progression of atherosclerosis in patients with coronary artery disease. Circulation. E345-E346.
  • 2008. The effect of homocysteine-lowering B-vitamin intervention on angiographic coronary artery disease may be adverse - A WENBIT sub-study. Circulation. E334-E334.
  • 2008. Homocysteine lowering B-vitamin therapy improves coronary flow in patients with stable coronary artery disease, a WENBIT substudy. Circulation. E487-E487.
  • 2008. Homocysteine lowering B-vitamin therapy and in-stent restenosis. A WENBIT sub study. Circulation. E472-E473.
  • 2008. Homocysteine and markers of immune activation as predictors of mortality in stable angina patients. Circulation. E351-E351.
  • 2008. Effect of cobalamin supplementation in infants: A randomized, controlled trial. Pediatrics. S109-S110.
  • 2008. B6 vitamers and long term mortality in patients with stable angina. Circulation. E347-E347.
  • 2008. Asymmetric and symmetric dimethylarginine are weaker predictors than homocysteine of long-term mortality in both men and women with stable angina. Circulation. E342-E342.
  • 2007. Predictors of plasma choline and betaine: The Hordaland Homocysteine Study. Clinical Chemistry and Laboratory Medicine. A18-A19.
  • 2007. Plasma uptake of methyl donors from wheat fractions by human subjects. Proceedings of the Nutrition Society. 114A-114A.
  • 2007. Folate metabolism genes and the risk of orofacial clefts. American Journal of Epidemiology. S118-S118.
  • 2005. The Effect of Homocysteine Lowering Therapy on Inflammatory Markers Neopterin and CRP in Patients with Stable Coronary Artery Disease. A substudy of the Western Norway B-vitamin Intervention Trial (WENBIT). Haematalogica Reports. 66-66.
  • 2005. Effect of homocysteine lowering therapy on coronary endothelial function in patients with stable coronary artery disease. A substudy of the Western Norway B-vitamin Intervention Trial (WENBIT). European Heart Journal. 477-477.
  • 2005. Effect of Homocysteine Lowering Therapy on Coronary Endothelial Function in Patients with Stable Coronary Artery Disease. Haematalogica Reports. 10-10.
Academic literature review
  • 2017. Inflammation, vitamin B6 and related pathways. 10-27.
  • 2015. Direct and functional biomarkers of vitamin B6 status. 33-70.
  • 2015. Biomarkers of nutrition for development-Folate review. 1636S-1680S.
  • 2013. Quantifying the dose-response relationship between circulating folate concentrations and colorectal cancer in cohort studies: a meta-analysis based on a flexible meta-regression model. 1028-1037.
  • 2013. Mechanistic perspective on the relationship between pyridoxal 5'-phosphate and inflammation. 239-244.
  • 2013. Dietary intake and biological measurement of folate: A qualitative review of validation studies. 562-581.
  • 2011. Use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for multiplex genotyping. 1-29.
  • 2010. Circulating folate, vitamin B-12, homocysteine, vitamin B-12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. 1632-1642.
  • 2008. Måling av metylmalonsyre, homocystein og metionin ved kobalamin- og folatmangel og homocystinuri. 690-693.
  • 2007. Review: Quantitative profiling of folate and one-carbon metabolism in large-scale epidemiological studies by mass spectrometry. 1737-1745.
  • 2004. Facts and recommendations about total homocysteine determinations: An expert opinion. 3-32.

More information in national current research information system (CRIStin)

Research groups